Clinical Trial Update: DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a doravirine/islatravir combination in antiretroviral-treatment-naïve adults with HIV-1 infection; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Doravirine (doravirine)
• Islatravir (Islatravir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV-1 Infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING